Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Prostatic Neoplasms 20Breast Neoplasms 6Polycystic Ovary Syndrome 4Infertility 4Uterine Anomalies 1Sleep Wake Disorders 1Salpingitis 1Salivary Gland Neoplasms 1Primary Ovarian Insufficiency 1Pregnancy, Ectopic 1Neoplasm Metastasis 1Myofibroma 1Metabolic Syndrome 1Lymphoma 1Leiomyoma 1Infertility, Female 1Hypogonadism 1Hodgkin Disease 1Fatty Liver 1Fatigue 1Endometritis 1Endometriosis 1Bulbo-Spinal Atrophy, X-Linked 1Breast Cancer Invasive Nos 1Adenocarcinoma 1

Interventions

cetrorelix 1Triptorelin Pamoate 1Menotropins 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Gonadotropins 1Chorionic Gonadotropin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Salpingitis × Triptorelin Pamoate × Clear all
NCT04071574 2023-05-09

CS-EOSP-ICSI

Lebanese University

Phase 1/2 Completed
200 enrolled
Gynecologic

Uterine Anomalies, Endometriosis, Endometritis, Infertility, Infertility, Female, Leiomyoma, Polycystic Ovary Syndrome, Pregnancy, Ectopic, Salpingitis, Primary Ovarian Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡